Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Liposarcoma|CRC|Prostate Cancer|Breast Neoplasms|Adenocarcinoma of Lung|Solid Tumors
Interventions: DRUG: PF-07220060|COMBINATION_PRODUCT: Letrozole|COMBINATION_PRODUCT: Fulvestrant|DRUG: Midazolam|COMBINATION_PRODUCT: Enzalutamide
Sponsor: Pfizer